Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Vanesa Quiroga García"'
Autor:
Vanesa Quiroga García, David López Sisamon, Mireia Margelí Vila, Max Hardy-Werbin, Beatriz Cirauqui, Ana Belén Blanca, Lyan Tobey Robaina
Publikováno v:
Anti-Cancer Drugs. 27:464-469
Cancer patients with severe renal dysfunction represent a challenge for the physician. This is the first case report on the use of denosumab in a dialysis patient with bone metastases. We present the clinical case of a 45-year-old woman who had hepat
Autor:
Javier Salvador Bofill, Fernando Moreno Anton, Cesar Augusto Rodriguez Sanchez, Elena Galve Calvo, Cristina Hernando Melia, Eva Maria Ciruelos Gil, Maria Vidal, Begoña Jiménez-Rodriguez, Luis De la Cruz Merino, Noelia Martínez Jañez, Rafael Villanueva Vazquez, Ruben de Toro Salas, Antonio Anton Torres, Isabel Manuela Alvarez Lopez, Joaquin Gavila Gregori, Vanesa Quiroga Garcia, Elena Vicente Rubio, Juan De la Haba-Rodriguez, Santiago Gonzalez-Santiago, Nieves Diaz Fernandez, Agusti Barnadas Molins, Blanca Cantos Sanchez de Ibargüen, Juan Ignacio Delgado Mingorance, Meritxell Bellet Ezquerra, Sonia de Casa, Asuncion Gimeno, Miguel Martin
Publikováno v:
Breast, Vol 66, Iss , Pp 77-84 (2022)
Background: Breast cancer is the most common malignancy and the second leading cause of cancer-related mortality in Spanish women. Ribociclib in combination with endocrine therapy (ET) has shown superiority in prolonging survival in patients with hor
Externí odkaz:
https://doaj.org/article/dad241cf2af94fb9adb70457754b6c11
Autor:
Maria Iciar Pascual Miguel, Nuria Pardo Aranda, Antonio Mariscal Martínez, Vanesa Quiroga García, Laia Capdevila Riera, Clara Rodríguez Caruncho, Mireia Margelí Vila, Clara Lezcano Rubio, Beatriz Cirauqui Cirauqui, Sara Vizcaya Martín
Publikováno v:
Universitat Autònoma de Barcelona
Journal of Medical Case Reports
Journal of Medical Case Reports
Introduction Taxanes have demonstrated effectiveness in the treatment of breast cancer, the most common type of cancer in women. The toxicity profile of taxanes (including skin toxicities) induces dose adjustment, delay, or discontinuation, which pre